Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, New York.
The Columbia University Renal Epidemiology (CURE) Group, New York, New York.
JAMA Netw Open. 2021 Apr 1;4(4):e215718. doi: 10.1001/jamanetworkopen.2021.5718.
The proportion of living donor kidney transplants from donors unrelated to their recipients is increasing in the US.
To examine the association between donor-recipient biological relationship and allograft survival after living donor kidney transplant.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used Organ Procurement and Transplantation Network data on US adult living donor kidney transplants (n = 86 154) performed from January 1, 2000, to December 31, 2014, excluding cases in which recipients previously received a kidney transplant (n = 10 342) or key data were missing (n = 2832). Last follow-up was March 20, 2020.
Donor-recipient biological relationship.
The primary outcome was death-censored allograft failure. Univariate and multivariable time-to-event analyses were performed for death-censored allograft failure for the overall cohort, then separately for recipients with and without primary diagnoses of cystic kidney disease and for transplants from African American and non-African American donors.
Among the 72 980 transplant donor and recipients included in the study (median donor age, 41 years; interquartile range [IQR], 32-50 years; 43 990 [60%] female; 50 014 [69%] White), 43 174 (59%) donors and recipients were biologically related and 29 806 (41%) were unrelated. Donors related to their recipients were younger (median [IQR] age, 39 [31-48] vs 44 [35-52] years) and less likely to be female (24 848 [58%] vs 19 142 [64%]) or White (26 933 [62%] vs 23 081 [77%]). Recipients related to their donors were younger (median [IQR] age, 48 [34-58] vs 50 [40-58] years), more likely to be female (18 035 [42%] vs 10 530 [35%]), and less likely to have cystic kidney disease (2530 [6%] vs 4600 [15%]). Related pairs had fewer HLA mismatches overall (median [IQR], 3 [2-3] vs 5 [4-5]). After adjustment for HLA mismatches, donor and recipient characteristics, and transplant era, donor-recipient biological relationship was associated with higher death-censored allograft failure (hazard ratio, 1.05; 95% CI, 1.01-1.10; P = .03). When stratified by primary disease, this association persisted only for recipients without cystic kidney disease. When stratified by donor race, this association persisted only for transplants from African American donors.
In this cohort study, living donor kidney transplants from donors biologically related to their recipients had higher rates of allograft failure than transplants from donors unrelated to their recipients after HLA matching was accounted for. Further study is needed to determine which genetic or socioenvironmental factors are associated with this finding.
在美国,与受者无亲属关系的活体供肾移植的比例正在增加。
研究活体供肾移植中供受者生物学关系与移植物存活之间的关系。
设计、地点和参与者:本回顾性队列研究使用了美国成人活体供肾移植(n=86154)的数据,这些移植是从 2000 年 1 月 1 日至 2014 年 12 月 31 日进行的,不包括之前接受过肾移植的受者(n=10342)或关键数据缺失的受者(n=2832)。最后一次随访是在 2020 年 3 月 20 日。
供受者生物学关系。
主要结局是死亡相关的移植物失功。对整个队列进行了死亡相关移植物失功的单变量和多变量时间事件分析,然后分别对原发性囊性肾病和来自非裔美国人和非非裔美国供者的移植受者进行了分析。
在这项研究中,包括了 72980 名移植供者和受者(中位供者年龄,41 岁;四分位间距[IQR],32-50 岁;43174[60%]为女性;50014[69%]为白人),43174 名(59%)供者和受者有亲属关系,29806 名(41%)无亲属关系。与受者有亲属关系的供者更年轻(中位数[IQR]年龄,39[31-48]岁比 44[35-52]岁),女性比例较低(24848[58%]比 19142[64%]),白人比例较低(26933[62%]比 23081[77%])。与供者有亲属关系的受者更年轻(中位数[IQR]年龄,48[34-58]岁比 50[40-58]岁),女性比例较高(18035[42%]比 10530[35%]),囊性肾病的比例较低(2530[6%]比 4600[15%])。总体上,亲属配对的 HLA 错配较少(中位数[IQR],3[2-3]比 5[4-5])。在调整 HLA 错配、供受者特征和移植年代后,供受者的生物学关系与较高的死亡相关移植物失功相关(风险比,1.05;95%CI,1.01-1.10;P=0.03)。按主要疾病分层时,这种关联仅存在于没有囊性肾病的受者中。按供者种族分层时,这种关联仅存在于来自非裔美国供者的移植中。
在这项队列研究中,与受者有亲属关系的活体供肾移植的移植物失功率高于与受者无亲属关系的活体供肾移植,这与 HLA 匹配后有关。需要进一步研究以确定哪些遗传或社会环境因素与这一发现有关。